TY - JOUR
T1 - Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis
AU - Di Sante, Gabriele
AU - Tolusso, Barbara
AU - Fedele, Anna Laura
AU - Gremese, Elisa
AU - Alivernini, Stefano
AU - Nicolo', Chiara
AU - Ria, Francesco
AU - Ferraccioli, Gianfranco
PY - 2015
Y1 - 2015
N2 - Rheumatoid arthritis (RA) is characterized by chronic joint inflammation and associates with HLA-DRB1*04. The Collagen IIp261-273-specific T cell repertoire in the peripheral blood of DR4 + patients at the onset of the disease shows a restricted TCR-beta chain usage among which the most frequent is TRBV25. To define whether this group of DR4-restricted collagen-specific shared T cell could represent markers of active-severe disease and response to therapy, 90 subjects affected by early-RA were enrolled in the study; peripheral blood mononuclear cells were cultured with or without the human collagen II peptide p261-273 and were examined by immunoscope analysis for the usage of the previously identified shared TCR-beta chains. We report that the presence of T cells carrying rearrangement TRBV25 associated with HLA-DR haplotype and disease activity. HLA-DRB1* haplotypes 04-04, 04-01 and 04-11 were significantly associated with usage of TRBV25, higher disease activity at the onset of disease and poor response to DMARDs. Finally, the HLA-DRB1* haplotype appeared complementary with current serologic tools to predict good and poor responders in a treat to target strategy. The data reported here offer clues to predict the course of the disease and to foresee personalized treatments in RA patients.
AB - Rheumatoid arthritis (RA) is characterized by chronic joint inflammation and associates with HLA-DRB1*04. The Collagen IIp261-273-specific T cell repertoire in the peripheral blood of DR4 + patients at the onset of the disease shows a restricted TCR-beta chain usage among which the most frequent is TRBV25. To define whether this group of DR4-restricted collagen-specific shared T cell could represent markers of active-severe disease and response to therapy, 90 subjects affected by early-RA were enrolled in the study; peripheral blood mononuclear cells were cultured with or without the human collagen II peptide p261-273 and were examined by immunoscope analysis for the usage of the previously identified shared TCR-beta chains. We report that the presence of T cells carrying rearrangement TRBV25 associated with HLA-DR haplotype and disease activity. HLA-DRB1* haplotypes 04-04, 04-01 and 04-11 were significantly associated with usage of TRBV25, higher disease activity at the onset of disease and poor response to DMARDs. Finally, the HLA-DRB1* haplotype appeared complementary with current serologic tools to predict good and poor responders in a treat to target strategy. The data reported here offer clues to predict the course of the disease and to foresee personalized treatments in RA patients.
KW - ACPA
KW - ACPA, anti-cyclic citrullinated peptide antibodies
KW - APCs, antigen presenting cells
KW - CDR3, complementarity-determining region 3
KW - CRP, C-reactive protein
KW - Clonotypes
KW - Coll261-273, human collagen derived peptide
KW - DAS, disease activity score
KW - Disease activity
KW - ERA, early rheumatoid arthritis
KW - ESR, erythrocyte sedimentation rate
KW - GWAS, genome wide association studies
KW - HAQ, Health Assessment Questionnaire
KW - HLA, histocompatibility leucocyte antigen
KW - HLA-DRB1
KW - MHC, major histocompatibility complex
KW - PBMC, peripheral blood mononuclear cells
KW - RF, rheumatoid factor
KW - RT-PCR, reverse transcription polymerase chain reaction
KW - SJC, swollen joint count
KW - SNP, single nucleotide polymorphism
KW - TCR, T cell receptor
KW - TJC, tender joint count
KW - TRBJ, junctional beta chain gene of TCR
KW - TRBV 25
KW - TRBV, variable beta chain gene of TCR
KW - ACPA
KW - ACPA, anti-cyclic citrullinated peptide antibodies
KW - APCs, antigen presenting cells
KW - CDR3, complementarity-determining region 3
KW - CRP, C-reactive protein
KW - Clonotypes
KW - Coll261-273, human collagen derived peptide
KW - DAS, disease activity score
KW - Disease activity
KW - ERA, early rheumatoid arthritis
KW - ESR, erythrocyte sedimentation rate
KW - GWAS, genome wide association studies
KW - HAQ, Health Assessment Questionnaire
KW - HLA, histocompatibility leucocyte antigen
KW - HLA-DRB1
KW - MHC, major histocompatibility complex
KW - PBMC, peripheral blood mononuclear cells
KW - RF, rheumatoid factor
KW - RT-PCR, reverse transcription polymerase chain reaction
KW - SJC, swollen joint count
KW - SNP, single nucleotide polymorphism
KW - TCR, T cell receptor
KW - TJC, tender joint count
KW - TRBJ, junctional beta chain gene of TCR
KW - TRBV 25
KW - TRBV, variable beta chain gene of TCR
UR - http://hdl.handle.net/10807/78802
U2 - 10.1016/j.ebiom.2015.11.019
DO - 10.1016/j.ebiom.2015.11.019
M3 - Article
SN - 2352-3964
VL - 2
SP - 2037
EP - 2045
JO - EBioMedicine
JF - EBioMedicine
ER -